Mounjaro only FDA-approved for diabetes Wegovy FDA-approved for weight loss Insurance coverage by indication Why Zepbound may be better for weight loss Zepbound vs Ozempic Different Indications Weight loss medication vs diabetes medicationkey differences explained
GLP-1 (glucagon-like peptide-1) Acts in the brain to curb appetite and cravings, so most people feel full sooner and snack less
Employers and health plans should evaluate GLP-1s within the context of total cost of care and implement strategies that balance access, outcomes, and sustainability
The most common: mild nausea, constipation, or reduced appetite, particularly in the first 48 weeks
Event: Plaintiffs Respond to Defendants Statement of the Case Date: May 3, 2024 Notes: Legal counsel for plaintiffs in the Ozempic lawsuit filed a statement in response to the defenses position statement
The manuscript has been read and approved by all the authors for submission to this journal for consideration for publication